Skip to main content
Top
Published in: Journal of Endocrinological Investigation 1/2021

01-01-2021 | Congenital Adrenal Hyperplasia | Original Article

Genetic profiling of CAH Egyptian children: rapid guide to clinical interpretation of common mutations

Authors: F. Elmougy, M. Elsharkawy, M. Hafez, S. A. Atty, H. Baz, A. Ibrahim, H. Soliman, S. Ekladious, M. Abdullatif, G. Thabet, N. Rady, A. Afif, A. Tolba, Z. Zaki, N. Musa

Published in: Journal of Endocrinological Investigation | Issue 1/2021

Login to get access

Abstract

Objectives

The prevalence of CAH in Egypt is reported to be ten times more than that of the worldwide prevalence. The study aimed at genetic screening of children diagnosed with 21-alpha hydroxylase deficiency congenital adrenal hyperplasia (21OHD-CAH). In addition, the study offers a rapid and easy guide for clinical reporting of common mutations for endocrinologists.

Methods

A cohort of 174 unrelated Egyptian children with 21OHD-CAH were screened for 11 common CYP21A2 gene mutations using a strip hybridization assay, and then, bioinformatics analysis was done to report the pathogenicity of the common mutations for clinical classification.

Results

The most common mutations were I2 splice and p.Q318X. Deletions/conversions comprised 45.9% of the cohort, whereas 7.4% of the cases were negative for all mutations. The least positively detected point mutations were p.P453S, cluster E6, p.R483P, and p.L307FS, which were detected in fewer than 5% of cases.

Conclusion

Strip hybridization assay is a rapid screening tool for the diagnosis of CAH. The authors hypothesized an easy and rapid scheme for clinical interpretation of the strip results to gain the highest value of the strip in diagnosis.
Literature
1.
go back to reference White PC, Grossberger D, Onufer BJ, Chaplin DD, New MI, Dupont B et al (1985) Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sci 82(4):1089–1093PubMedCrossRef White PC, Grossberger D, Onufer BJ, Chaplin DD, New MI, Dupont B et al (1985) Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sci 82(4):1089–1093PubMedCrossRef
2.
go back to reference Speiser PW, White PC, Dupont J, Zhu D, Mercado AB, New MI (1994) Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by allele-specific hybridization and Southern blot. Hum Genet 93(4):424–428PubMedCrossRef Speiser PW, White PC, Dupont J, Zhu D, Mercado AB, New MI (1994) Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by allele-specific hybridization and Southern blot. Hum Genet 93(4):424–428PubMedCrossRef
3.
go back to reference Donohouse P, Parker K, Migeon CJ (1995) Congenital adrenal hyperplasia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York Donohouse P, Parker K, Migeon CJ (1995) Congenital adrenal hyperplasia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York
4.
go back to reference Mazen IA (2017) Clinical management of gender in Egypt: intersexuality and transsexualism. Arch Sex Behav 46(2):369–372PubMedCrossRef Mazen IA (2017) Clinical management of gender in Egypt: intersexuality and transsexualism. Arch Sex Behav 46(2):369–372PubMedCrossRef
5.
go back to reference Bertholf RL, Cooper M, Winter WE (2018) 66—Adrenal cortex, 6th edn. Elsevier Inc., Amsterdam Bertholf RL, Cooper M, Winter WE (2018) 66—Adrenal cortex, 6th edn. Elsevier Inc., Amsterdam
6.
go back to reference Tayel SM, Ismael H, Kandil H, Rabuh ARA, Sallam H (2011) Congenital adrenal hyperplasia in Alexandria, Egypt: a high prevalence justifying the need for a community-based newborn screening program. J Trop Pediatr 57(3):232–234PubMedCrossRef Tayel SM, Ismael H, Kandil H, Rabuh ARA, Sallam H (2011) Congenital adrenal hyperplasia in Alexandria, Egypt: a high prevalence justifying the need for a community-based newborn screening program. J Trop Pediatr 57(3):232–234PubMedCrossRef
7.
go back to reference Trapp CM, Levine LS, Oberfield SE (2018) Congenital adrenal hyperplasia. In Pediatric Endocrinology. Springer, Cham, pp 311–334 Trapp CM, Levine LS, Oberfield SE (2018) Congenital adrenal hyperplasia. In Pediatric Endocrinology. Springer, Cham, pp 311–334
8.
go back to reference Rabbani B, Mahdieh N, Haghi Ashtiani M-T, Akbari M-T, Rabbani A (2011) Molecular diagnosis of congenital adrenal hyperplasia in Iran: focusing on CYP21A2 Gene. Iran J Pediatr 21(2):139–150PubMedPubMedCentral Rabbani B, Mahdieh N, Haghi Ashtiani M-T, Akbari M-T, Rabbani A (2011) Molecular diagnosis of congenital adrenal hyperplasia in Iran: focusing on CYP21A2 Gene. Iran J Pediatr 21(2):139–150PubMedPubMedCentral
9.
go back to reference Carvalho DF, Miranda MC, Gomes LG, Madureira G, Marcondes JAM, Billerbeck AEC et al (2016) Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction. Eur J Endocrinol 175:107PubMedCrossRef Carvalho DF, Miranda MC, Gomes LG, Madureira G, Marcondes JAM, Billerbeck AEC et al (2016) Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction. Eur J Endocrinol 175:107PubMedCrossRef
10.
go back to reference Strachan T (1994) Molecular pathology of 21-hydroxylase deficiency. J Inherit Metab Dis 17:430–441PubMedCrossRef Strachan T (1994) Molecular pathology of 21-hydroxylase deficiency. J Inherit Metab Dis 17:430–441PubMedCrossRef
11.
go back to reference Tusie-Luna M-T, White PC (1995) Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sci 92(23):10796–10800PubMedCrossRef Tusie-Luna M-T, White PC (1995) Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sci 92(23):10796–10800PubMedCrossRef
12.
go back to reference Németh S, Riedl S, Kriegshäuser G, Baumgartner-Parzer S, Concolino P, Neocleous V et al (2012) Reverse-hybridization assay for rapid detection of common CYP21A2 mutations in dried blood spots from newborns with elevated 17-OH progesterone. Clin Chim Acta 414:211–214PubMedCrossRef Németh S, Riedl S, Kriegshäuser G, Baumgartner-Parzer S, Concolino P, Neocleous V et al (2012) Reverse-hybridization assay for rapid detection of common CYP21A2 mutations in dried blood spots from newborns with elevated 17-OH progesterone. Clin Chim Acta 414:211–214PubMedCrossRef
13.
go back to reference Parajes S, Quinterio C, Domínguez F, Loidi L (2007) A simple and robust quantitative PCR assay to determine CYP21A2 gene dose in the diagnosis of 21-hydroxylase deficiency. Clin Chem 53(9):1577–1584PubMedCrossRef Parajes S, Quinterio C, Domínguez F, Loidi L (2007) A simple and robust quantitative PCR assay to determine CYP21A2 gene dose in the diagnosis of 21-hydroxylase deficiency. Clin Chem 53(9):1577–1584PubMedCrossRef
14.
go back to reference Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R et al (2018) VarSome: the human genomic variant search engine. Bioinformatics 35(11):1978–1980PubMedCentralCrossRef Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R et al (2018) VarSome: the human genomic variant search engine. Bioinformatics 35(11):1978–1980PubMedCentralCrossRef
15.
go back to reference Balraj P, Lim PG, Sidek H, WuKhoo LLSB (2013) Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia. J Endocrinol Invest 36(6):366–374PubMed Balraj P, Lim PG, Sidek H, WuKhoo LLSB (2013) Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia. J Endocrinol Invest 36(6):366–374PubMed
16.
go back to reference New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D et al (2013) Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci USA 110(7):2611–2616PubMedCrossRef New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D et al (2013) Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci USA 110(7):2611–2616PubMedCrossRef
17.
go back to reference Finkielstain GP, Chen W, Mehta SP, Fujimura FK, Hanna RM, Van Ryzin C et al (2011) Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 96(1):E161–E172PubMedCrossRef Finkielstain GP, Chen W, Mehta SP, Fujimura FK, Hanna RM, Van Ryzin C et al (2011) Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 96(1):E161–E172PubMedCrossRef
18.
go back to reference Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424PubMedPubMedCentralCrossRef Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424PubMedPubMedCentralCrossRef
19.
go back to reference Tadmouri GO, Sastry KS, Chouchane L (2014) Arab gene geography: from population diversities to personalized medical genomics. Global Cardiol Sci Pract 4:394–408 Tadmouri GO, Sastry KS, Chouchane L (2014) Arab gene geography: from population diversities to personalized medical genomics. Global Cardiol Sci Pract 4:394–408
20.
go back to reference Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP (2000) Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 85(3):1059–1065PubMedCrossRef Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP (2000) Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 85(3):1059–1065PubMedCrossRef
21.
go back to reference Kharrat M, Tardy V, M’Rad R, Maazoul F, Jemaa LB, Refaï M et al (2004) Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation. J Clin Endocrinol Metab 89(1):368–374PubMedCrossRef Kharrat M, Tardy V, M’Rad R, Maazoul F, Jemaa LB, Refaï M et al (2004) Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation. J Clin Endocrinol Metab 89(1):368–374PubMedCrossRef
22.
go back to reference Higashi Y, Hiromasa T, Tanae A, Miki T, Nakura J, Kondo T et al (1991) Effects of individual mutations in the P-450 (C21) pseudogene on the P-450 (C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J Biochem 109(4):638–644PubMedCrossRef Higashi Y, Hiromasa T, Tanae A, Miki T, Nakura J, Kondo T et al (1991) Effects of individual mutations in the P-450 (C21) pseudogene on the P-450 (C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J Biochem 109(4):638–644PubMedCrossRef
23.
go back to reference Lajic S, Wedell A (1996) An intron 1 splice mutation and a nonsense mutation (W23X) in CYP21 causing severe congenital adrenal hyperplasia. Hum Genet 98(2):182–184PubMedCrossRef Lajic S, Wedell A (1996) An intron 1 splice mutation and a nonsense mutation (W23X) in CYP21 causing severe congenital adrenal hyperplasia. Hum Genet 98(2):182–184PubMedCrossRef
24.
go back to reference Stikkelbroeck NMML, Hoefsloot LH, De Wijs IJ, Otten BJ, Hermus RMM, Sistermans E (2003) CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in the Netherlands: six novel mutations and a specific cluster of four mutations. J Clin Endocrinol Metab 88(8):3852–3859PubMedCrossRef Stikkelbroeck NMML, Hoefsloot LH, De Wijs IJ, Otten BJ, Hermus RMM, Sistermans E (2003) CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in the Netherlands: six novel mutations and a specific cluster of four mutations. J Clin Endocrinol Metab 88(8):3852–3859PubMedCrossRef
25.
go back to reference Globerman H, Amor M, Parker KL, New MI, White PC (1988) Nonsense mutation causing steroid 21-hydroxylase deficiency. J Clin Investig 82(1):139PubMedCrossRef Globerman H, Amor M, Parker KL, New MI, White PC (1988) Nonsense mutation causing steroid 21-hydroxylase deficiency. J Clin Investig 82(1):139PubMedCrossRef
26.
go back to reference Higashi Y, Tanae A, Inoue H, Hiromasa T, Fujii-Kuriyama Y (1988) Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450 (C21)] deficiency in humans: possible gene conversion products. Proc Natl Acad Sci 85(20):7486–7490PubMedCrossRef Higashi Y, Tanae A, Inoue H, Hiromasa T, Fujii-Kuriyama Y (1988) Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450 (C21)] deficiency in humans: possible gene conversion products. Proc Natl Acad Sci 85(20):7486–7490PubMedCrossRef
27.
go back to reference Wilson RC, Mercado AB, Cheng KC, New MI (1995) Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 80(8):2322–2329PubMed Wilson RC, Mercado AB, Cheng KC, New MI (1995) Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 80(8):2322–2329PubMed
28.
go back to reference Tukel T, Uyguner O, Wei JQ, Yuksel-Apak M, Saka N, Song DX et al (2003) A novel semiquantitative polymerase chain reaction/enzyme digestion-based method for detection of large scale deletions/conversions of the CYP21 gene and mutation screening in Turkish families with 21-hydroxylase deficiency. J Clin Endocrinol Metab 88(12):5893–5897PubMedCrossRef Tukel T, Uyguner O, Wei JQ, Yuksel-Apak M, Saka N, Song DX et al (2003) A novel semiquantitative polymerase chain reaction/enzyme digestion-based method for detection of large scale deletions/conversions of the CYP21 gene and mutation screening in Turkish families with 21-hydroxylase deficiency. J Clin Endocrinol Metab 88(12):5893–5897PubMedCrossRef
29.
go back to reference Al-obaidi RGY, Al-musawi BMS, Al-zubaidi MAK, Oberkanins C, Németh S, Al-obaidi YGY (2016) Molecular analysis of CYP21A2 Gene mutations among Iraqi patients with congenital adrenal hyperplasia. Enzyme Res 2016:1–7CrossRef Al-obaidi RGY, Al-musawi BMS, Al-zubaidi MAK, Oberkanins C, Németh S, Al-obaidi YGY (2016) Molecular analysis of CYP21A2 Gene mutations among Iraqi patients with congenital adrenal hyperplasia. Enzyme Res 2016:1–7CrossRef
30.
go back to reference Sido AG, Weber MM, Sido PG, Clausmeyer S, Heinrich U, Schulze E (2005) 21-Hydroxylase and 11??-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 90(10):5769–5773CrossRef Sido AG, Weber MM, Sido PG, Clausmeyer S, Heinrich U, Schulze E (2005) 21-Hydroxylase and 11??-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 90(10):5769–5773CrossRef
31.
go back to reference Elmougy F, Sharaf S, Hafez M, Khattab A, Abou-Yousef H, Elsharkawy M et al (2018) CYP21A2 genetic profile in 14 Egyptian children with suspected congenital adrenal hyperplasia: a diagnostic challenge. Ann N Y Acad Sci 1415(1):11–20PubMedCrossRef Elmougy F, Sharaf S, Hafez M, Khattab A, Abou-Yousef H, Elsharkawy M et al (2018) CYP21A2 genetic profile in 14 Egyptian children with suspected congenital adrenal hyperplasia: a diagnostic challenge. Ann N Y Acad Sci 1415(1):11–20PubMedCrossRef
32.
go back to reference Robins T, Barbaro M, Lajic S, Wedell A (2005) Not all amino acid substitutions of the common cluster E6 mutation in CYP21 cause congenital adrenal hyperplasia. J Clin Endocrinol Metabol 90(4):2148–2153CrossRef Robins T, Barbaro M, Lajic S, Wedell A (2005) Not all amino acid substitutions of the common cluster E6 mutation in CYP21 cause congenital adrenal hyperplasia. J Clin Endocrinol Metabol 90(4):2148–2153CrossRef
33.
go back to reference Tusie-Luna MT, Traktman P, White PC (1990) Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. J Biol Chem 265(34):20916–20922PubMedCrossRef Tusie-Luna MT, Traktman P, White PC (1990) Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. J Biol Chem 265(34):20916–20922PubMedCrossRef
34.
go back to reference Zhang H-J, Yang J, Zhang M-N, Zhang W, Liu J-M, Wang W-Q et al (2009) Variations in the promoter of CYP21A2 gene identified in a Chinese patient with simple virilizing form of 21-hydroxylase deficiency. Clin Endocrinol 70(2):201–207CrossRef Zhang H-J, Yang J, Zhang M-N, Zhang W, Liu J-M, Wang W-Q et al (2009) Variations in the promoter of CYP21A2 gene identified in a Chinese patient with simple virilizing form of 21-hydroxylase deficiency. Clin Endocrinol 70(2):201–207CrossRef
35.
go back to reference Nikoshkov A, Lajic S, Holst M, Wedell A, Luthman H (1997) Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency. J Clin Endocrinol Metabol 82(1):194–199 Nikoshkov A, Lajic S, Holst M, Wedell A, Luthman H (1997) Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency. J Clin Endocrinol Metabol 82(1):194–199
36.
go back to reference Chiou SH, Hu MC, Chung BC (1990) A missense mutation at Ile172––Asn or Arg356––Trp causes steroid 21-hydroxylase deficiency. J Biol Chem 265(6):3549–3552PubMedCrossRef Chiou SH, Hu MC, Chung BC (1990) A missense mutation at Ile172––Asn or Arg356––Trp causes steroid 21-hydroxylase deficiency. J Biol Chem 265(6):3549–3552PubMedCrossRef
Metadata
Title
Genetic profiling of CAH Egyptian children: rapid guide to clinical interpretation of common mutations
Authors
F. Elmougy
M. Elsharkawy
M. Hafez
S. A. Atty
H. Baz
A. Ibrahim
H. Soliman
S. Ekladious
M. Abdullatif
G. Thabet
N. Rady
A. Afif
A. Tolba
Z. Zaki
N. Musa
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 1/2021
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-020-01271-z

Other articles of this Issue 1/2021

Journal of Endocrinological Investigation 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.